TriVisc* Knee Pain Relief

Simplifying Access & Reimbursement for Healthcare Providers

TriVisc* is a clinically proven viscosupplement designed to relieve knee pain caused by osteoarthritis in patients who have not responded to conservative treatments. Administered through a series of three intra-articular injections, TriVisc* helps restore joint function and improve mobility. Grole Industries is committed to ensuring seamless access to TriVisc* for healthcare providers, offering comprehensive reimbursement support, coding guidance, and payment assistance through our dedicated Reimbursement Navigator program. Let us assist you in navigating the reimbursement process to deliver optimal care for your patients.

Streamlining Knee Pain Treatment

Reimbursement and Support for Healthcare Providers

    • HCPCS Code: J7329 (Hyaluronan or derivative, TriVisc for intra-articular injection, 1 mg)

    • CPT Codes: 20610 (Without ultrasound), 20611 (With ultrasound)

    • NDC Code: 50653-0006-04 (Used as a device proxy for medical device reimbursement)

  • Our Reimbursement Navigator program offers support with benefit verification, prior authorization, coding guidance, and claims assistance, ensuring a smooth experience for healthcare providers.

  • If a claim for TriVisc* is denied, we help identify the cause and assist in resubmitting claims or appealing denials. Our team can guide providers through the process, ensuring that all necessary documentation is submitted to avoid delays in reimbursement.